Cargando…

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia

The efficacy of chemotherapy in pediatric acute lymphoblastic leukemia (ALL) patients has significantly increased in the last 20 years; as a result, the focus of research is slowly shifting from trying to increase survival rates to reduce chemotherapy-related toxicity. At the present time, the corne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gervasini, Guillermo, Vagace, Jose M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2012
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504364/ https://www.ncbi.nlm.nih.gov/pubmed/23189085 http://dx.doi.org/10.3389/fgene.2012.00249

Ejemplares similares

Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2020)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
por: Moradveisi, Borhan, et al.
Publicado: (2019)

Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
por: Gándara-Mireles, Jesús Alonso, et al.
Publicado: (2021)

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
por: Xu, Meng, et al.
Publicado: (2022)

Genetic Polymorphisms Associated to Folate Transport as Predictors of Increased Risk for Acute Lymphoblastic Leukemia in Mexican Children
por: Zaruma-Torres, Fausto, et al.
Publicado: (2016)

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
por: Yang, Qing-Yan, et al.
Publicado: (2021)

Psychological Impact of Chemotherapy for Childhood Acute Lymphoblastic Leukemia on Patients and Their Parents
por: Sherief, Laila M., et al.
Publicado: (2015)

Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
por: Cao, Minyuan, et al.
Publicado: (2020)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2019)

Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy
por: Schmiegelow, Kjeld, et al.
Publicado: (2017)

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
por: Gregers, J, et al.
Publicado: (2015)

After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood
por: Scheede-Bergdahl, Celena, et al.
Publicado: (2013)

Genetic variants of genes involved in thiopurine metabolism pathway are associated with 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia patients from Ethiopia
por: Ali, Awol Mekonnen, et al.
Publicado: (2023)

Anthracycline Induced Cardiac Disorders in Childhood Acute Lymphoblastic Leukemia: A Single-Centre, Retrospective, Observational Study
por: Yu, Hui, et al.
Publicado: (2021)

Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia
por: Hao, Qishan, et al.
Publicado: (2022)

Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia
por: Dobrovinskaya, Oxana, et al.
Publicado: (2016)

ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia
por: Svasdisant, Patpetra, et al.
Publicado: (2023)

Case report: Olverembatinib monotherapy: the chemotherapy-free regimen for an elderly patient with relapsed Ph-positive acute lymphoblastic leukemia
por: Ding, Jianghua, et al.
Publicado: (2023)

Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients
por: Lavanderos, María A., et al.
Publicado: (2019)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
por: Umerez, Maitane, et al.
Publicado: (2017)

Childhood B-acute lymphoblastic leukemia: a genetic update
por: Woo, Jennifer S, et al.
Publicado: (2014)

Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces
por: Gallardo-Pérez, Moisés M., et al.
Publicado: (2023)

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy
por: Lüke, Florian, et al.
Publicado: (2021)

Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia
por: Eskandari, Ebrahim, et al.
Publicado: (2018)

The CEBPE rs2239633 genetic polymorphism on susceptibility to childhood acute lymphoblastic leukemia: an updated meta-analysis
por: Liu, Jin, et al.
Publicado: (2021)

The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021)

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report
por: Fu, Shuang, et al.
Publicado: (2023)

A Risk Scoring Model for High-Dose Methotrexate-Induced Liver Injury in Children With Acute Lymphoblastic Leukemia Based on Gene Polymorphism Study
por: He, Xia, et al.
Publicado: (2021)

Synthesized evidence for childhood acute lymphoblastic leukemia
por: Onyije, Felix M., et al.
Publicado: (2023)

Association of ABCC2 −24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia
por: Liu, Yan, et al.
Publicado: (2014)

High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
por: Zhang, Yazhi, et al.
Publicado: (2020)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor‐1 and osteonecrosis risk in childhood acute lymphoblastic leukemia
por: Sherief, Laila M., et al.
Publicado: (2021)

Obesity in patients with acute lymphoblastic leukemia in childhood
por: Iughetti, Lorenzo, et al.
Publicado: (2012)

Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation
por: Kong, Seom Gim, et al.
Publicado: (2014)

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019)

Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
por: Mogensen, Pernille Rudebeck, et al.
Publicado: (2020)

Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
por: Kwiecinska, Kinga, et al.
Publicado: (2018)

Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan
por: Alsous, Mervat, et al.
Publicado: (2018)

Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
por: Turati, Virginia A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jim7iktrdg7pu2neg9tgdp6d7u